Doubling down on Cybin Back in January, Horizons’ (PYSK.NE) ETF held a relatively balanced portfolio of psychedelics companies. No company made up more than 10% of its holdings, with…
top psychedelics stocks
Why some stocks are undervalued A lot of things go into determining a company’s share price, but in a young emerging industry like psychedelics, many of the traditional measurements…
In the cannabis sector, there is a wide net of different types of companies from growers to extractors to logistics & tech and everything in-between. In the earlier days…
Early money Earlier this week California introduced a bill to decriminalize psychedelics. If passed, SB 519 will approve the use of mushrooms, MDMA, LSD, mescaline, and ibogaine for…
Esketamine Braxia Scientific (BRAX.C), formerly known as Champignon Brands had a rough 2020. It was a down year for many of us, but Champignon really found itself in trouble…
There are two options when it comes to ingesting psychedelics, natural or synthetic. People have been tripping balls eating raw natural mushrooms for thousands of years, so why…
Humming in Q1 I’ve had a rough year, but Revive (RVV.C) sure hasn’t. With a portfolio based around psychedelics, cannabis, and diseases – this company has made 3…